Follicular thyroid carcinoma: Prognostic factors and the role of radioiodine

Cancer

Volumn 95, Issue 3, 2002, Pages 488-498

  Chow, Sin Ming ^a   Law, Stephen C K ^a   Mendenhall, William M ^b   Au, Siu Kie ^a   Yau, Stephen ^a   Yuen, Kam Tong ^a   Law, Chi Ching ^a   Lau, Wai Hon ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Distant metastases; Follicular thyroid carcinoma; Prognostic factors; Radioiodine

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLICULAR CARCINOMA; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SUBTOTAL THYROIDECTOMY; THORAX RADIOGRAPHY; THYROID CARCINOMA; TREATMENT OUTCOME; WHOLE BODY SCINTISCANNING;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 0036682380     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10683     Document Type: Article

References (69)

1. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996
2. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996
3. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases
4. Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients
5. Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and outcome
6. A prognostic index for thyroid carcinoma. A study of the EORTC Thyroid Cancer Cooperative Group
7. Survival of differentiated thyroid carcinoma studied in 500 patients
8. Survival and prognostic factors in differentiated thyroid cancer - A multivariate analysis of 1,055 cases
9. Differentiated thyroid cancer long-term impact of initial therapy
10. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma
11. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients
12. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups
13. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer
14. Morbidity and mortality in follicular thyroid cancer
15. Follicular carcinoma of the thyroid
16. Thyroid hormone and the cardiovascular system
17. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine
18. Excess triiodothyronine as a risk factor of coronary events
19. Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women
20. The risk factors and bone mineral density in women on long-term levothyroxine treatment
21. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance
22. Prolonged suppressive L-thyroxine therapy. Longitudinal study of the effect of LT4 on bone mineral density and bone metabolism markers in 71 patients
23. Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women
24. Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma
25. Regression models and life tables
26. Tumors of the thyroid and parathyroid glands
27. Diagnosis, treatment, and outcome of follicular thyroid carcinoma
28. Thyroid cancer: A multivariate analysis on influence of treatment on long-term survival
29. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991
30. Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience
31. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
32. Outcome of 249 patients attending a nuclear medicine department with well differentiated thyroid cancer; a 23 year review
33. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome
34. Follicular carcinoma of the thyroid gland: Prognostic factors, treatment, and survival
35. Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients
36. Follicular thyroid carcinoma with capsular invasion alone: A nonthreatening malignancy
37. Prognostic factors for thyroid carcinoma. A population-based study of 15698 cases from the Surveillance, Epidemiology and End Results (SEER) Program 1973-1991
38. Selective treatment of differentiated thyroid carcinoma
39. The results of various modalities of treatment of well differentiated thyroid carcinomas: A retrospective review of 1599 patients
40. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma
41. Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma
42. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients
43. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma
44. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays
45. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment
46. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma
47. Sialadenitis following I-131 therapy for thyroid carcinoma: Concise communication
48. Local reactions to radioiodine in the treatment of thyroid cancer
49. Haematological effects from radioiodine treatment of thyroid carcinoma
50. The long-term hazards of the treatment of thyroid cancer with radioiodine
51. Cancer incidence following treatment of hyperthyroidism
52. Leukaemias and cancers following iodine-131 administration for thyroid cancer
53. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study
54. Leukemia after a small dose of radioiodine for metastatic thyroid cancer
55. Preleukemia following large dose radioiodine therapy for metastatic thyroid carcinoma
56. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective
57. Testicular function after radioiodine therapy for thyroid carcinoma
58. 131I for thyroid cancer
59. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine
60. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients
61. Genetic risk after high dose radioiodine therapy with regard to gonadal dose
62. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas
63. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
64. Prognostic factors in follicular carcinoma of the thyroid: A study of 198 cases
65. Pure follicular thyroid carcinoma: Impact of therapy in 214 patients
66. Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings
67. Insular carcinoma: A distinct de novo entity among follicular carcinomas of the thyroid gland